Partnership for Safe Medicines Statement on Foreign Drug Importation Efforts in the U.S. Senate (updated)

Washington, D.C. (Updated June 13, 2022) – Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, released the following statement in advance of the Senate HELP Committee’s June 14th Executive Session. “The amendments offered to include foreign drug importation in S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, are…

[...]

Since 2015, fentanyl has changed the drug landscape

Counterfeit pills made with fentanyl have proliferated across the U.S. since 2015, killing people in all 50 states. The pills have become heavily trafficked, easier to find and more deadly.

This infographic shows how the fentanyl pill trade has changed.

[...]